Anti-Human Ganglioside GD2 Recombinant Antibody(Naxitamab)
-
产品编号
YR1539
-
别名
科研级 Naxitamab (那昔妥单抗 ), Anti-Ganglioside GD2 Recombinant Antibody, Research Grade Naxitamab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Naxitamab (那昔妥单抗 ), Anti-Ganglioside GD2 Recombinant Antibody, Research Grade Naxitamab |
| Catalog Number | YR1539 |
| Molecular Name | Naxitamab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Naxitamab, sold under the brand name Danyelza, is an anti-cancer medication. It is a monoclonal antibody used in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) for people one year of age and older with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow demonstrating a partial response, minor response, or stable disease to prior therapy. |
| CAS Number | 1879925-92-4 |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | Ganglioside GD2[Homo sapiens] |
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
